MLSS Milestone Scientific Inc.

AMEX · US · Healthcare · Medical Instruments & Supplies · milestonescientific.com

0.3700USD+0.79%Mkt Cap: 33.53M $P/E: —1d ago

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, C…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap33.53M USD

Enterprise Value31.13M USD

Revenue (TTM)9.42M USD

Gross Profit6.41M USD

Net Income (TTM)-5.72M USD

Revenue/Share0.11 USD

Last Price0.3700 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees15

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-10.49

PEG—

EV/EBITDA-7.73

EV/Revenue3.30

P/S3.53

P/B9.41

EPS (TTM)-0.04

EPS (Forward)-0.04

52W Range

0.220039% of range0.6000

52W High0.6000 USD

52W Low0.2200 USD

Profitability

Gross Margin71.40%

Oper. Margin-37.36%

EBITDA Margin-42.73%

Profit Margin-63.76%

ROE-203.45%

ROA-73.30%

Growth

Revenue Growth22.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.92M USD

CapEx (TTM)15.12K USD

FCF Margin10.42%

FCF Yield2.93%

Net Debt-1.45M USD

Net Debt/EBITDA0.36

Balance Sheet

Debt/Equity0.36

Current Ratio1.85

Quick Ratio0.71

Book Value/Sh0.04 USD

Cash/Share0.02 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:3

Split DateJan 14, 2004

Analyst Consensus

Rating—

Target (Mean)1.250 USD

Upside (mean)+237.8%

Target Range1.000 USD – 1.500 USD

1.000+237.8% to mean1.500

# Analysts2

Ownership

Shares Out.90.61M

Float74.89M

Insiders16.01%

Institutions5.30%

Short Interest

Short Ratio0.9d

Short % Float0.12%

Short % Out.0.10%

Shares Short91.29K

Short (prev mo.)209.36K

Technical

SMA 500.4460 (-17.0%)

SMA 2000.3513 (+5.3%)

Beta1.13

S&P 52W Chg15.77%

Avg Vol (30d)112.68K

Avg Vol (10d)108.32K

Technical Indicators

RSI (14)37.1

MACD-0.0192

MACD Signal-0.0145

MACD Hist.-0.0047

BB Upper0.4571 USD

BB Middle0.4066 USD

BB Lower0.3561 USD

BB Width24.84%

ATR (14)0.0334 USD

Vol Ratio (20d)0.40x